Anti-spike IgG4 and Fc effector responses: The impact of SARS-CoV-2 vaccine platform–specific priming and immune imprinting

Related articles

1. Kinetics and specificity of orthoflaviviruses NS1 IgG after Zika virus infection in Yellow fever and dengue immunized individuals: a memory recall hypothesis

   This article has 12 authors:

   1. Solène Marquine
   2. Nazli Ayhan
   3. Kelly Meneyrol
   4. Erwan Le Dault
   5. Sarah Attoumani
   6. Elif Nurtop
   7. Gilda Grard
   8. Aurélie Trignol
   9. Bruno Coutard
   10. Marie Mura
   11. Sébastien Briolant
   12. Cyril Badaut

2. Impaired memory B-cell formation after mRNA-based COVID-19 booster vaccination in patients with inflammatory bowel disease receiving anti-TNF treatment

   This article has 16 authors:

   1. Paul A. Gill
   2. Lachlan R. Bradbury
   3. Alina Wang
   4. Julie Hogg
   5. Kathryn Demase
   6. Jo McKenzie
   7. Holly A. Fryer
   8. Daryl Geers
   9. Luca M. Zaeck
   10. Irene Boo
   11. P. Mark Hogarth
   12. Heidi E. Drummer
   13. Rory D. de Vries
   14. Robyn E. O’Hehir
   15. Miles P. Sparrow
   16. Menno C. van Zelm

3. Convergent IGHV3-53/3-66 antibodies elicited by Omicron BA.1 infection broadly neutralize emerging SARS-CoV-2 variants

   This article has 24 authors:

   1. Naveenchandra Suryadevara
   2. Seth J. Zost
   3. John M. Powers
   4. Bernadeta Dadonaite
   5. Pavlo Gilchuk
   6. Elad Binshtein
   7. Suzanne Scheaffer
   8. Sarah R Leist
   9. Luke Myers
   10. Silvia Ravera
   11. Lily E. Adams
   12. Laura S. Handal
   13. Shruthi Kannan
   14. Edgar Davidson
   15. Benjamin J. Doranz
   16. Andrew Trivette
   17. Masako Abney
   18. Doan C. Nguyen
   19. F. Eun-Hyung Lee
   20. Robert H. Carnahan
   21. Jesse D. Bloom
   22. Ralph S. Baric
   23. Michael S. Diamond
   24. James E. Crowe